Physical and functional interactions between Daxx and TSG101

Biochemical and Biophysical Research Communications

Volumn 316, Issue 3, 2004, Pages 827-833

  Muromoto, Ryuta ^a   Sugiyama, Kenji ^b   Yamamoto, Tetsuya ^a   Oritani, Kenji ^c   Shimoda, Kazuya ^d   Matsuda, Tadashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Daxx; Repression; Transcription; TSG101

Indexed keywords

DAXX PROTEIN; GLUCOCORTICOID RECEPTOR; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARRIER PROTEINS; CELL LINE; CELL NUCLEUS; COS CELLS; CYTOPLASM; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; NUCLEAR PROTEINS; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 1642268973     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.126     Document Type: Article

References (35)

1. Yang X., Khosravi-Far R., Chang H.Y., Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell. 89:1997;1067-1076.
2. Michaelson J.S., Bader D., Kuo F., Kozak C., Leder P. Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development. Genes Dev. 13:1999;1918-1923.
3. Pluta A.F., Earnshaw W.C., Goldberg I.G. Interphase-specific association of intrinsic centromere protein CENP-C with HDaxx, a death domain-binding protein implicated in Fas-mediated cell death. J. Cell Sci. 111:1998;2029-2041.
4. Hollenbach A.D., Sublett J.E., McPherson C.J., Grosveld G. The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. EMBO J. 18:1999;3702-3711.
5. Emelyanov A.V., Kovac C.R., Sepulveda M.A., Birshtein B.K. The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells. J. Biol. Chem. 277:2002;11156-11164.
6. Li R., Pei H., Watson D.K., Papas T.S. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes. Oncogene. 19:2000;745-753.
7. Ryu S.W., Chae S.K., Kim E. Interaction of Daxx, a Fas binding protein, with sentrin and Ubc9. Biochem. Biophys. Res. Commun. 279:2000;6-10.
8. Ishov A.M., Sotnikov A.G., Negorev D., Vladimirova O.V., Neff N., Kamitani T., Yeh E.T., Strauss III J.F., Maul G.G. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147:1999;221-234.
9. Li H., Leo C., Zhu J., Wu X., O'Neil J., Park E.J., Chen J.D. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol. Cell. Biol. 20:2000;1784-1796.
10. Lin D.Y., Lai M.Z., Ann D.K., Shih H.M. Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential. J. Biol. Chem. 278:2003;15958-15965.
11. Lin D.Y., Shih H.M. Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration. J. Biol. Chem. 277:2002;25446-25456.
12. Ko Y.G., Kang Y.S., Park H., Seol W., Kim J., Kim T., Park H.S., Choi E.J., Kim S. Apoptosis signal-regulating kinase 1 controls the proapoptotic function of death-associated protein (Daxx) in the cytoplasm. J. Biol. Chem. 276:2001;39103-39106.
13. Ecsedy J.A., Michaelson J.S., Leder P. Homeodomain-interacting protein kinase 1 modulates Daxx localization, phosphorylation, and transcriptional activity. Mol. Cell. Biol. 23:2003;950-960.
14. Lehembre F., Muller S., Pandolfi P.P., Dejean A. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Oncogene. 20:2001;1-9.
15. Li L., Cohen S.N. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell. 85:1996;319-329.
16. Ruland J., Sirard C., Elia A., MacPherson D., Wakeham A., Li L., de la Pompa J.L., Cohen S.N., Mak T.W. p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc. Natl. Acad. Sci. USA. 98:2001;1859-1864.
17. Koonin E.V., Abagyan R.A. TSG101 may be the prototype of a class of dominant negative ubiquitin regulators. Nat. Genet. 16:1997;330-331.
18. Ponting C.P., Cai Y.D., Bork P. The breast cancer gene product TSG101: a regulator of ubiquitination? J. Mol. Med. 75:1997;467-469.
19. Katzmann D.J., Babst M., Emr S.D. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell. 106:2001;145-155.
20. Bishop N., Woodman P. TSG101/mammalian VPS23 and mammalian VPS28 interact directly and are recruited to VPS4-induced endosomes. J. Biol. Chem. 276:2001;11735-11742.
21. Watanabe M., Yanagi Y., Masuhiro Y., Yano T., Yoshikawa H., Yanagisawa J., Kato S. A putative tumor suppressor, TSG101, acts as a transcriptional suppressor through its coiled-coil domain. Biochem. Biophys. Res. Commun. 245:1998;900-905.
22. Hittelman A.B., Burakov D., Iniguez-Lluhi J.A., Freedman L.P., Garabedian M.J. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J. 18:1999;5380-5388.
23. Sun Z., Pan J., Hope W.X., Cohen S.N., Balk S.P. Tumor susceptibility gene 101 protein represses androgen receptor transactivation and interacts with p300. Cancer. 86:1999;689-696.
24. Muromoto R., Sugiyama K., Takachi A., Imoto S., Sato N., Yamamoto T., Oritani K., Shimoda K., Matsuda T. Physical and functional interactions between Daxx and DNA methyltransferase 1 associated protein, DMAP1. J. Immunol. 172:2004;2985-2993.
25. Rountree M.R., Bachman K.E., Baylin S.B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 25:2000;269-277.
26. Muromoto R., Yamamoto T., Yumioka T., Sekine Y., Sugiyama K., Shimoda K., Oritani K., Matsuda T. Daxx enhances Fas-mediated apoptosis in a murine pro-B cell line, BAF3. FEBS Lett. 540:2003;223-228.
27. Bresnick E.H., John S., Berard D.S., LeFebvre P., Hager G.L. Glucocorticoid receptor-dependent disruption of a specific nucleosome on the mouse mammary tumor virus promoter is prevented by sodium butyrate. Proc. Natl. Acad. Sci. USA. 87:1990;3977-3981.
28. Li L., Liao J., Ruland J., Mak T.W., Cohen S.N. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. Proc. Natl. Acad. Sci. USA. 98:2001;1619-1624.
29. Matsuda T., Yamamoto T., Kishi H., Yoshimura A., Muraguchi A. SOCS-1 can suppress CD3zeta- and Syk-mediated NF-AT activation in a non-lymphoid cell line. FEBS Lett. 472:2000;235-240.
30. Michaelson J.S., Leder P. RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX. J. Cell Sci. 116:2003;345-352.
31. Torii S., Egan D.A., Evans R.A., Reed J.C. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J. 18:1999;6037-6049.
32. Chang H.Y., Yang X., Baltimore D. Dissecting Fas signaling with an altered-specificity death-domain mutant: requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation. Proc. Natl. Acad. Sci. USA. 96:1999;1252-1256.
33. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
34. Perlman R., Schiemann W.P., Brooks M.W., Lodish H.F., Weinberg R.A. TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell Biol. 3:2001;708-714.
35. Hollenbach A.D., McPherson C.J., Mientjes E.J., Iyengar R., Grosveld G. Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J. Cell Sci. 115:2002;3319-3330.